{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T23:30:47Z","timestamp":1792798247773,"version":"4.5.0"},"reference-count":10,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:00:00Z","timestamp":1762473600000},"content-version":"vor","delay-in-days":37,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007937","name":"Peking University","doi-asserted-by":"publisher","award":["RDL2024-17"],"award-info":[{"award-number":["RDL2024-17"]}],"id":[{"id":"10.13039\/501100007937","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82402103"],"award-info":[{"award-number":["82402103"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004826","name":"Beijing Natural Science Foundation","doi-asserted-by":"publisher","award":["7244425"],"award-info":[{"award-number":["7244425"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ero.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["EULAR Rheumatology Open"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.ero.2025.11.003","type":"journal-article","created":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T01:08:26Z","timestamp":1764810506000},"page":"430-433","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["A case of adult-onset Still disease complicated by macrophage activation syndrome and toxic epidermal necrolysis"],"prefix":"10.1016","volume":"1","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2201-074X","authenticated-orcid":false,"given":"Haojie","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huaqun","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ero.2025.11.003_bib0001","first-page":"424","article-title":"Preliminary criteria for classification of adult Still\u2019s disease","volume":"19","author":"Yamaguchi","year":"1992","journal-title":"J Rheumatol"},{"issue":"2","key":"10.1016\/j.ero.2025.11.003_bib0002","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/pbc.21039","article-title":"HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis","volume":"48","author":"Henter","year":"2007","journal-title":"Pediatr Blood Cancer"},{"issue":"12","key":"10.1016\/j.ero.2025.11.003_bib0003","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1136\/ard-2024-225851","article-title":"EULAR\/PReS recommendations for the diagnosis and management of Still\u2019s disease, comprising systemic juvenile idiopathic arthritis and adult-onset Still\u2019s disease","volume":"83","author":"Fautrel","year":"2024","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.ero.2025.11.003_bib0004","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1007\/s40744-023-00600-x","article-title":"Risk of macrophage activation syndrome in patients with adult-onset Still\u2019s disease treated with IL-1 and IL-6 inhibitors: a meta-analysis and single-center experience","volume":"10","author":"Adachi","year":"2023","journal-title":"Rheumatol Ther"},{"issue":"5","key":"10.1016\/j.ero.2025.11.003_bib0005","doi-asserted-by":"crossref","first-page":"59","DOI":"10.55563\/clinexprheumatol\/lp2u7g","article-title":"Clinical characteristics of macrophage activation syndrome in adult-onset Still\u2019s disease","volume":"39 Suppl 132","author":"Gao","year":"2021","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.ero.2025.11.003_bib0006","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jaut.2018.07.018","article-title":"A comprehensive review on adult onset Still\u2019s disease","volume":"93","author":"Giacomelli","year":"2018","journal-title":"J Autoimmun"},{"issue":"16","key":"10.1016\/j.ero.2025.11.003_bib0007","doi-asserted-by":"crossref","first-page":"8912","DOI":"10.1039\/C9RA00060G","article-title":"Re-Du-Ning inhalation solution exerts suppressive effect on the secretion of inflammatory mediators via inhibiting IKK\u03b1\/\u03b2\/I\u03baB\u03b1\/NF-\u03baB, MAPKs\/AP-1, and TBK1\/IRF3 signaling pathways in lipopolysaccharide stimulated RAW 264.7 macrophages","volume":"9","author":"Zhang","year":"2019","journal-title":"RSC Adv"},{"key":"10.1016\/j.ero.2025.11.003_bib0008","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.2147\/CCID.S378106","article-title":"Effectiveness and safety of early short-course, moderate- to high-dose glucocorticoids for the treatment of Stevens-Johnson syndrome\/toxic epidermal necrolysis: a retrospective study","volume":"15","author":"Ye","year":"2022","journal-title":"Clin Cosmet Investig Dermatol"},{"issue":"2","key":"10.1016\/j.ero.2025.11.003_bib0009","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.alit.2022.02.001","article-title":"Drug allergy and autoimmune diseases","volume":"71","author":"Watanabe","year":"2022","journal-title":"Allergol Int"},{"issue":"5","key":"10.1016\/j.ero.2025.11.003_bib0010","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1093\/jbcr\/irab058","article-title":"A fatal case of toxic epidermal necrolysis combined with vanishing bile duct syndrome and hemophagocytic lymphohistiocytosis","volume":"42","author":"Wier","year":"2021","journal-title":"J Burn Care Res"}],"container-title":["EULAR Rheumatology Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S305070812500103X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S305070812500103X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T21:12:47Z","timestamp":1766005967000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S305070812500103X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":10,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S305070812500103X"],"URL":"https:\/\/doi.org\/10.1016\/j.ero.2025.11.003","relation":{},"ISSN":["3050-7081"],"issn-type":[{"value":"3050-7081","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A case of adult-onset Still disease complicated by macrophage activation syndrome and toxic epidermal necrolysis","name":"articletitle","label":"Article Title"},{"value":"EULAR Rheumatology Open","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ero.2025.11.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V. on behalf of European Alliance of Associations for Rheumatology (EULAR).","name":"copyright","label":"Copyright"}]}}